Core Viewpoint - Beiding Co., Ltd. reported a strong performance in Q3 2025, with revenue of 220 million yuan, a year-on-year increase of 19.0%, and a net profit attributable to shareholders of 30 million yuan, up 289.0% year-on-year, driven by a focus on core self-owned brands and a low base effect [1][2]. Revenue Growth - The revenue growth in Q3 2025 is primarily attributed to the continuous increase in domestic sales of Beiding's self-owned brands, with domestic revenue reaching 140 million yuan, a year-on-year increase of 31.7% [2]. - National subsidies have positively impacted the growth of self-owned brands, enhancing consumer spending and benefiting Beiding due to its mid-to-high-end brand positioning and strong brand reputation [2]. Gross Margin Improvement - Beiding's gross margin in Q3 2025 was 46.4%, reflecting a year-on-year increase of 3.5 percentage points, likely due to the rising proportion of high-margin self-owned brand revenue [2]. - The proportion of self-owned brand revenue increased from 77.0% in H1 2024 to 82.5% in H1 2025, contributing to the improvement in gross margin [2]. Net Profit Margin Growth - The net profit margin attributable to shareholders in Q3 2025 was 12.4%, up 8.6 percentage points year-on-year, driven by both the increase in gross margin and effective cost control [3]. - The company achieved a reduction in sales, management, R&D, and financial expense ratios, with a total decrease of 6.0 percentage points year-on-year, attributed to improved operational efficiency in overseas markets [3]. Investment Outlook - Beiding is positioned as a leading player in the small home appliance segment, with strong R&D capabilities and a focus on mid-to-high-end self-owned brands, which are expected to drive revenue and performance growth [4]. - The profit forecasts for 2025, 2026, and 2027 have been adjusted to 120 million yuan, 140 million yuan, and 160 million yuan respectively, with corresponding price-to-earnings ratios of 33, 28, and 24 times [4]. - The target price has been adjusted to 14.6 yuan, maintaining a "recommended" rating [4].

Core Viewpoint - The company has been deeply engaged in the pet food industry for nearly 30 years, utilizing both OEM and self-owned brands to drive growth, with significant international and domestic sales achievements [1] Group 1: Export Business - The company has established a global supply chain with production capacities in six countries, achieving an export revenue of 1.57 billion yuan, accounting for 65% of total revenue as of H1 2025 [1] - North America is the largest sales market, and the company has proactively built overseas production capacities to mitigate trade risks, with net profit margins for various overseas factories ranging from 13% to 21% [2] - The company’s export performance has significantly outperformed the industry during trade tensions and tariff increases [2] Group 2: Domestic Sales - The company has developed three core self-owned brands, "WANPY," "TOPTREES," and "ZEAL," capturing the mid-to-high-end domestic market, with domestic sales revenue reaching 860 million yuan, accounting for 35% of total revenue as of H1 2025 [1] - The pet food industry still has considerable growth potential, with a fragmented competitive landscape allowing leading domestic brands to increase market share [3] - The company’s product matrix is improving under its explosive product strategy, with significant online ranking improvements during promotional periods [3] Group 3: Profitability - The company has benefited from favorable raw material costs and exchange rates, leading to continuous improvement in gross margins, with expectations for further increases in gross and net profit margins due to a higher proportion of self-owned products [4] - Revenue projections for 2025-2027 are 5.42 billion, 6.54 billion, and 7.87 billion yuan, with year-on-year growth rates of 21.3%, 20.8%, and 20.3% respectively, and net profits of 470 million, 580 million, and 740 million yuan, with growth rates of 18.3%, 24.8%, and 27.2% respectively [4]

Investment Rating - The report maintains a "Buy" rating for the company [2][7]. Core Insights - The company reported a revenue of 3.86 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 21.1%. The net profit attributable to the parent company was 333 million yuan, up 18.2% year-on-year [7]. - The company's proprietary brand revenue is accelerating, with online GMV for its brands increasing by 24% year-on-year in Q1-Q3 2025. The "Wang Pi" brand showed significant growth, with a 30% increase in Q3 [7]. - The overseas business is steadily growing, with the company expanding its global supply chain, including new factories in Mexico and improvements in existing facilities in the U.S. and Canada [7]. Financial Data and Profit Forecast - Total revenue is projected to reach 5.44 billion yuan in 2025, with a year-on-year growth rate of 21.7%. The net profit attributable to the parent company is expected to be 451 million yuan, reflecting a growth of 14.5% [6][9]. - The gross margin is forecasted to improve to 30.9% in 2025, with a return on equity (ROE) of 15.8% [6][9]. - The company anticipates continued revenue growth of 22% in 2026 and 23% in 2027, with net profits expected to grow by 26% and 28% respectively [7].

Summary of Yuanfei Pet's Conference Call Industry and Company Overview - **Company**: Yuanfei Pet - **Industry**: Pet Products, focusing on pet food and cleaning supplies - **Key Business Segments**: - Foreign trade OEM (Original Equipment Manufacturer) - Agency brands - Self-owned brands Core Points and Arguments - **Strong Online Performance**: In 2024, Yuanfei Pet's online operations showed outstanding performance with a year-on-year growth rate doubling, launching three self-owned brands in March targeting different price segments in the dog snack market [2][3] - **Revenue Growth**: Overall revenue increased by approximately 45% year-on-year in the first half of the year, with foreign trade OEM revenue growing about 30% and pet snacks growing at 50% [2][3] - **Profitability**: While profits remained flat in the first half, the second quarter saw a significant profit growth of 31% year-on-year. The company expects continued strong performance in the third quarter with profit margins similar to the second quarter [2][4] - **Production Capacity**: The company reported a high order saturation in foreign trade with a production capacity utilization rate of 120%-130%. New production capacity in Cambodia is expected to be operational by mid-next year [2][4] - **Stock Incentive Plan**: A stock incentive plan was introduced covering the self-owned brand team in Hangzhou and mid-level managers in the Cambodia factory, reflecting confidence in revenue performance [4] Additional Important Insights - **Business Structure**: Foreign trade OEM accounted for about 86% of total revenue last year, serving overseas retailers with pet snacks and cleaning supplies. The company has strategically positioned production in Cambodia to mitigate tariff impacts [5][6] - **Market Strategy**: The company is leveraging Douyin (TikTok) for brand promotion and aims to enhance its self-owned brand's market presence, targeting a revenue of 30 million yuan in 2024 and 100 million yuan in 2025 [3][7] - **Future Growth Potential**: Yuanfei Pet views its self-owned brands as a crucial growth engine, with a mid-term goal of reaching 500 million yuan in three years. The company plans to enhance brand image through platform operations and private domain management [8][9] - **Valuation Outlook**: The company is expected to have significant upside potential in its valuation, with a solid business structure and stable profitability. The foreign trade OEM and agency brands are valued at 15-20 times PE, while self-owned brands are evaluated on a PS basis [9]

Core Insights - The company is transitioning from OEM to its own high-end brand, focusing on the "Wujie" brand, which has shown significant growth in the motorcycle market, particularly in overseas markets with structural opportunities [1][2]. Group 1: Brand Development and Product Strategy - The company has accelerated the development of its own brand product line, with revenue from the "Wujie" brand increasing by 30.2% year-on-year to 1.98 billion yuan in the first half of 2025, indicating a clear trend of growth driven by its own brand [1]. - The company is implementing a strategy of "creating explosive products and intelligent manufacturing," continuously enhancing its motorcycle product matrix, including high-performance models and expanding its all-terrain vehicle product line [1]. Group 2: International Expansion - The company is aggressively pursuing international markets with a "1+N" strategy, focusing on product, brand, and capacity exports. It has gained significant market share in Spain (6.5%) and Portugal (4.4%) for its models, demonstrating strong brand recognition [2]. - The company plans to leverage its established brand presence in Europe to expand into Latin America and Southeast Asia, which represent substantial market opportunities [2]. Group 3: Operational Efficiency - Following the completion of the restructuring of its controlling shareholder, the company has implemented operational efficiency measures, resulting in a decrease in sales and management expense ratio by 1.65 percentage points to 3.5% in the first half of 2025, enhancing profitability [3]. - The company aims to optimize supply chain management in collaboration with its new controlling shareholder, enhancing market competitiveness through supply chain synergies [3]. Group 4: Financial Projections and Valuation - The company maintains its previous revenue growth forecasts of 15.3%, 17.6%, and 18.4% for 2025-2027, with net profit growth projected at 69%, 24%, and 21%, reaching 1.90 billion, 2.36 billion, and 2.85 billion yuan respectively [4]. - The company is valued at a target PE of 23.6x for 2025, corresponding to a target price of 21.71 yuan, reflecting positive progress in its overseas brand development [4].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of 21.71 RMB [7]. Core Insights - The company is focusing on enhancing its self-owned brand product line, with revenue from the "Wuji" brand increasing by 30.2% year-on-year to 1.98 billion RMB in the first half of 2025, indicating a clear trend of self-owned brand driving growth [2]. - The company is aggressively expanding its overseas market presence through a "1+N" strategy, achieving a market share of 6.5% in Spain and 4.4% in Portugal, with plans to penetrate further into Germany and France [3]. - Operational efficiency is being improved, with a decrease in selling and administrative expense ratio by 1.65 percentage points to 3.5% in the first half of 2025, enhancing profitability [4]. Summary by Sections Revenue and Profit Forecast - The company expects revenue growth of 15.3% in 2025, 17.6% in 2026, and 18.4% in 2027, with net profit attributable to the parent company projected to increase by 69% in 2025, 24% in 2026, and 21% in 2027, reaching 1.90 billion RMB, 2.36 billion RMB, and 2.85 billion RMB respectively [5][11]. Valuation Metrics - The company is projected to have a PE ratio of 23.6x for 2025, with a target price of 21.71 RMB based on this valuation [5][12]. Market Positioning - The company is enhancing its product matrix in the motorcycle segment, focusing on high-performance and personalized products to capture mainstream domestic racing and cruising markets [2]. Operational Strategy - The company is optimizing supply chain management in collaboration with its new controlling shareholder, aiming to create a smart supply chain to strengthen market competitiveness [4]. Financial Performance Indicators - The company’s revenue for 2024 is expected to be 16.82 billion RMB, with a year-on-year growth of 28.74%, and a projected net profit of 1.12 billion RMB, reflecting a significant increase of 92.19% [11].

Core Viewpoint - The company experienced a decline in revenue and net profit in the first half of 2025, but showed resilience in its domestic brand growth and improved profitability metrics [1][2][3] Financial Performance - In 1H2025, the company reported revenue of 728 million yuan, a decrease of 13.94% year-on-year, and a net profit of 79 million yuan, down 19.23% year-on-year [1] - The second quarter showed a slight improvement with revenue down 13.56% year-on-year and net profit up 1.15% year-on-year [1] Product Performance - Revenue from various product lines in 1H2025 included: - Livestock skin chew revenue of 232 million yuan (down 11.91%) with a gross margin of 28.08% (up 5.28 percentage points) - Plant-based chew revenue of 221 million yuan (down 25.72%) with a gross margin of 32.07% (up 3.12 percentage points) - Nutritional meat snacks revenue of 217 million yuan (up 14.35%) with a gross margin of 36.62% (up 6.75 percentage points) - Main and wet food revenue of 45 million yuan (down 44.74%) with a gross margin of 33.27% (up 11.04 percentage points) [2] International Business and Brand Strategy - The overseas business faced challenges with a 21% year-on-year decline in foreign sales due to order rhythm from overseas clients, but the company aims to enhance its resilience by expanding non-US customer outreach [2] - The domestic brand continued to grow rapidly, focusing on product innovation with new launches in the first half of the year and plans for further product introductions in the second half [2] Profitability Metrics - The company achieved a gross margin of 31.98% in 1H2025, an increase of 5.63 percentage points, with a second quarter gross margin of 34.76% [3] - The net profit margin for 1H2025 was 11.00%, a decrease of 0.65 percentage points, with a second quarter net profit margin of 14.25% [3] Expense Ratios - The sales expense ratio increased by 1.65 percentage points to 7.66% due to higher investments in the domestic brand [3] - The management expense ratio rose by 2.64 percentage points to 8.53%, primarily due to increased operational expenses from New Zealand's natural products [3] Investment Outlook - The company forecasts net profits of 197 million yuan, 236 million yuan, and 281 million yuan for 2025-2027, with corresponding price-to-earnings ratios of 22.5, 18.7, and 15.8 times based on the closing price on August 26 [3]

Group 1: Report Industry Investment Rating - No relevant content provided Group 2: Core View of the Report - The company attaches great importance to shareholder returns and plans to conduct mid - term dividends under eligible conditions. It has made significant progress in brand strategy, product development, and market expansion, with strong potential for future development [24][25] Group 3: Summary by Related Catalogs 01. Research Basic Situation - The research object is Loncin General, belonging to the transportation equipment industry. The reception time was on August 26, 2025, and the listed company's reception staff included the chairman, general manager, independent directors, board secretary, and financial director [17] 02. Detailed Research Institutions - The reception objects include investors and others [20] 03. Research Institution Proportion - No relevant content provided 04. Main Content Data - **Dividend Policy**: In 2024, the company distributed cash dividends of 821 million yuan, accounting for 73.26% of the net profit attributable to shareholders of the listed company in 2024. The company's general meeting of shareholders has authorized the board of directors to formulate a mid - term dividend plan for 2025 [25] - **Sales and Service System**: The company is building the "Ji" service system and launched the Wujiji official APP in July. For the Southeast Asian market, it uses Malaysia as a strategic fulcrum to expand the market [26][27] - **Brand Strategy**: The company's independent brand strategy is progressing smoothly, with two independent brands, VOGE and LONCIN. The high - end independent brand revenue was 2.334 billion yuan, a year - on - year increase of 42.43%, accounting for about 24% of the company's operating income [27] - **Export Performance**: In the first half of this year, the export sales revenue of the Wujiji series products was 1.19 billion yuan, a year - on - year increase of 83.31%. The growth was mainly due to the increase in European market revenue, and the brand ranked among the top ten in the core markets of Spain and Italy [28] - **Engine R & D**: In the first half of the year, new products such as KEV250A and KEN460 were successfully mass - produced, and the engine matrix was further improved [29][30] - **Tricycle Business**: The sales revenue of tricycle products was 879 million yuan, a year - on - year increase of 38.68%. The export sales revenue was 489 million yuan, a year - on - year increase of 87.57%. The company is expanding domestic and overseas markets [31] - **Lawn Mower Robot**: The company's lawn mower robot uses a pure vision solution and a self - developed 3D vision algorithm. It is expected to complete mass - production preparations within the year [32] - **Response to Ranking Change**: The company congratulates Dachangjiang Group and is more determined to pursue the independent brand development path [34] - **Employee Incentive**: The new board of directors and management of the company will introduce an incentive plan in due course [35]

Group 1: Financial Performance - The overall gross margin for the company's proprietary brands is approximately 50% [1] - Revenue from proprietary brands is expected to grow nearly 30% year-on-year by 2024, indicating a strong growth trend [1] - The current revenue share from proprietary brands is relatively low, but is anticipated to increase with enhanced sales resource investment and product pipeline expansion [1] Group 2: Research and Development - The company is focusing its R&D investments primarily in the fields of antibodies and proteins [1] - As of the end of 2024, the Hangzhou antibody R&D center has developed over 2,900 SPUs (Standard Product Units) including paired antibodies and diagnostic antibodies [1] - The Nanjing protein R&D center has developed over 1,700 SPUs, including drug targets and cytokines, and has introduced new products like one-step Elisa kits [1] Group 3: Share Repurchase and Incentive Plans - In 2024, the company initiated a share repurchase plan, utilizing 25,987,076 CNY to buy back 927,600 shares, intended for equity incentives or employee stock ownership plans [1] - A new share repurchase plan is set to use between 15 million and 30 million CNY of its own funds for share buybacks aimed at capital reduction [1][2] - Future equity incentive plans will be introduced based on business development needs to enhance motivational effects [2] Group 4: Mergers and Acquisitions Strategy - The company aims to strengthen channel and R&D capabilities to better serve customers and provide diverse product offerings [2] - In terms of external growth, the company will seek potential upstream and downstream acquisition targets that align with its existing business, particularly in antibody-related applications [2]

Group 1: Company Product Structure - The company operates as a one-stop service provider in life sciences, offering reagents, consumables, instruments, and laboratory services, integrating both well-known domestic and international brands as well as its own brands [1] - In 2024, the revenue from the company's own brands increased by nearly 30% year-on-year, indicating a strong growth trend [1] Group 2: Own Brand Performance - The overall gross margin for the company's own brands is approximately 50% [1] - The revenue share from own brands is currently low, but it is expected to increase as the company invests more resources into sales and continues to enrich its product pipeline [1] Group 3: Shareholder Incentives - In 2024, the company initiated a share repurchase plan, utilizing a total of 25,987,076 CNY to repurchase 927,600 shares, which will be used for equity incentives or employee stock ownership plans [1] - Future equity incentive or employee stock ownership plans will be introduced based on business development needs [1] Group 4: Overseas Market Expansion - The company's business is primarily focused on the domestic market, but it plans to accelerate the internationalization of its own brand products based on R&D and domestic sales performance [2] - In 2024, the company established a subsidiary in Singapore to facilitate overseas expansion [2] - The company is actively enhancing product visibility through online promotions and participation in offline exhibitions to further accelerate overseas market development [2] Group 5: M&A Strategy - The company aims to strengthen channel capabilities and R&D capabilities to better serve customers and provide a diverse range of products and services [2] - In terms of external growth, the company will seek potential upstream and downstream acquisition targets that align with its existing business, particularly in antibody-related applications [2]